Skip to main content
Clinical Trials/NL-OMON54476
NL-OMON54476
Recruiting
Not Applicable

An intervention study on the effect of digital self-monitoring-based management of relapsing and remitting multiple sclerosis on self-efficacy, clinical outcomes and cost-effectiveness - Multiple sclerosis self-monitoring (MSSM)

Vrije Universiteit Medisch Centrum0 sites210 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
MS
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
210
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. A minimum age of 18 years.
  • 2\. Have a definite diagnosis of RRMS according to the revised McDonald 2017
  • 3\. Have a length of disease duration of \>\=12 months, from date of MS diagnosis.
  • 4\. Have clinical disease activity (reported relapses) and/or radiological
  • disease activity (new/enlarged T2 lesions or contrast\-enhancing lesions) within
  • the past 12 months.
  • 5\. Willing and able to install and use MS sherpa on own smartphone with Android
  • (version 4\.4 or higher) or iOS (version 9 or higher) operating system.
  • 6\. Willing to stay for treatment with the same hospital during the year of
  • 7\. Willing to follow the rules of conduct as described in Appendix A during the

Exclusion Criteria

  • 1\. EDSS of \> 6\.5 at baseline screening. 2\. Presence of a cognitive, visual
  • or upper extremity deficit that disables the use or measurements of MS sherpa
  • on the smartphone, as judged by the investigator. 3\. Concomitant use of health
  • monitoring apps or devices for MS during the study. 4\. Concomitant
  • participation in another intervention trial in MS.

Outcomes

Primary Outcomes

Not specified

Similar Trials